Polaryx Therapeutics (PLYX) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 71 192 sessions, February 2, 2026 to November 4, 2026
- Largest daily move
- +69.6% close of March 10, 2026
- 1-month change
- -13.5% closing prices, October 2, 2026 to November 4, 2026
Company Description
Polaryx Therapeutics (NASDAQ: PLYX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $89.7M.
PLYX has declined 13.5% over the past month. The last closing price was $1.80.
For FY2025, Polaryx Therapeutics reported net income of -$9.0M and diluted earnings per share of -$0.20.
This page collects what Stock Titan holds for PLYX, including price data, latest news, SEC filings, financial highlights, and short interest trends.
Stock Performance
Polaryx Therapeutics (PLYX) closed at $1.80 on November 4, 2026. Over the past month, the price has lost 13.5%.
PLYX Metrics & Rankings
Price returns through November 4, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Polaryx Therapeutics has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include clinical trial, private placement. View all PLYX news →
SEC Filings
Polaryx Therapeutics has filed 10 recent SEC filings, including 5 Form 8-K, 2 Form 10-Q, 1 Form 4, 1 Form ARS. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all PLYX SEC filings →
Financial Highlights
Polaryx Therapeutics reported operating income of -$7.8M in FY2025, and net income was -$9.0M. Diluted earnings per share stood at -$0.20. The company generated -$3.9M in operating cash flow. The current ratio was 8.55, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in Polaryx Therapeutics (PLYX) currently stands at 118.3 thousand shares, down 17.5% from the previous reporting period, representing 0.8% of the float. Since February 2026, short interest has increased by 352.0%.
Days to Cover History
Days to cover for Polaryx Therapeutics (PLYX) currently stands at 3.3 days, down 25.2% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since February 2026, the figure has increased by 233%. Across the settlements charted above, it has ranged from 1.0 to 6.4 days.
PLYX Company Profile & Sector Positioning
Polaryx Therapeutics (PLYX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing PLYX often look at related companies in the same sector, including Tonix Pharmaceuticals Holding Corp. (TNXP), NeOnc Technologies Holdings, Inc. (NTHI), Tiziana Life Sciences Ltd. (TLSA), Genelux Corporation (GNLX), and Rallybio Corporation (RLYB). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PLYX's relative position within its industry.